Sustainable and efficient 3D visualization of preclinical in-vivo studies in real-time.
Reference number | |
Coordinator | IVRS AB |
Funding from Vinnova | SEK 297 100 |
Project duration | June 2020 - February 2021 |
Status | Completed |
Venture | Innovative Startups |
Call | Innovative Startups step 1 spring 2020 |
Important results from the project
** Denna text är maskinöversatt ** The goal of the financing was to further develop the service by identifying the resources and activities required to develop the company´s market position, identify and create new long-term customer relationships and contacts, market research and analysis, and develop and validate the business model.
Expected long term effects
** Denna text är maskinöversatt ** IVRS has been able to establish new customers in need of preclinical studies. IVRS has also increased its net sales significantly from last year. IVRS´s business model has been created and it forms the basis for the company´s market position and business model validation.
Approach and implementation
** Denna text är maskinöversatt ** IVRS has developed and validated its business plan by presenting an extensive business model in order to clarify what is required for the company to succeed with its business concept on a large scale. The business model contains a revenue model and a delivery model. Validation has taken place in the form that we have tested our model against existing customers.